DRAGONFLY FILMS LTD

Company number 13041133 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

DRAGONFLY FILMS LTD - Analysis Report

Company Number: 13041133

Analysis Date: 2025-07-20 11:14 UTC

Financial Health Assessment for DRAGONFLY FILMS LTD as of 30 November 2024


1. Financial Health Score: C

Explanation:
The company has shown a significant turnaround from previous years’ distress but still faces liquidity challenges and relies on director loans to maintain operations. The net asset position has improved to a positive £5,126, indicating recovery from previous accumulated losses. However, ongoing negative working capital and limited cash reserves signal caution. The "C" grade reflects a company in recovery but not yet fully stable or robust in financial health.


2. Key Vital Signs

Metric 2024 Value Interpretation
Cash at Bank £1,884 Low cash reserves; tight liquidity "pulse"
Current Liabilities £9,818 Debts due within one year; reduced but still significant
Net Current Assets (Working Capital) £-7,934 Negative working capital: warning symptom of short-term liquidity issues
Net Assets (Shareholders’ Funds) £5,126 Positive equity; recovery from prior losses ("healthy tissue repair")
Tangible Fixed Assets £13,060 Investment in equipment; indicates business capacity for operations
Director Loan £4,759 (owed to director) Reliance on intra-company financing; potential risk if not repaid timely

3. Diagnosis: What the Financial Data Reveals

  • Symptom of Past Distress:
    From 2020 to 2023, the company bore substantial accumulated losses, reflected in negative net assets reaching nearly -£20,000. This is akin to a patient suffering from prolonged illness with depleted reserves.

  • Recent Recovery ("Healing Phase"):
    The 2024 accounts indicate a positive net asset position (£5,126), suggesting successful efforts to restore financial health, perhaps through improved operations or capital injections.

  • Liquidity Challenges ("Weak Pulse"):
    Despite improvement in equity, the company has negative working capital (£-7,934) and very limited cash (£1,884), indicating potential challenges in meeting short-term obligations without relying on director loans or external financing.

  • Asset Base ("Body Strength"):
    Tangible assets have increased to £13,060, showing investment in equipment, which is necessary for a video production business. This is a positive sign indicating capacity to generate future revenue.

  • Dependence on Director Loans ("Supportive IV Lines"):
    The director loan balance (£4,759) provides essential liquidity support but adds risk if the company cannot repay or replace this with operational cash flow.


4. Recommendations: Specific Actions to Improve Financial Wellness

  1. Improve Cash Flow Management:

    • Prioritize invoicing and collections to boost cash reserves, akin to stabilizing a patient's vital signs.
    • Tighten credit control and negotiate better payment terms with suppliers to ease working capital strain.
  2. Strengthen Working Capital:

    • Explore short-term financing options to cover the negative working capital gap and avoid liquidity crises.
    • Consider trimming non-essential expenses or optimizing inventory if applicable.
  3. Director Loan Management:

    • Develop a clear repayment plan for director loans or convert them to equity to reduce financial strain and improve balance sheet health.
  4. Enhance Profitability:

    • Focus on winning higher-margin projects or diversifying client base to generate sustainable profits and reduce accumulated losses.
  5. Regular Financial Monitoring:

    • Establish monthly financial reviews to monitor cash flow, liabilities, and asset utilization to detect early symptoms of distress.
  6. Contingency Planning:

    • Prepare for unforeseen downturns by building a cash buffer and maintaining access to emergency funding.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.